PemiBil: Efficacy and safety of pemigatinib in advanced cholangiocarcinoma with FGFR2 fusions/rearrangements in real-world, results of multicentric French cohort from ACABI consortium

This article has no abstract
Epistemonikos ID: fac1df9e4a98a33aff2cde1ad061f002966298ea
First added on: Feb 16, 2025